Skip to main content
IDENTIFYING PATIENTS

CHOOSE DUPIXENT AND
TRANSFORM THE MANAGEMENT
OF
PATIENTS WHO REMAIN
UNCONTROLLED DESPITE PPIs

Not actual patients

Are your patients showing
signs and symptoms of EoE?

Symptoms of
EoE1

ADULTS/ADOLESCENTS
(≥12 YEARS)

  • Dysphagia
  • Food impaction
  • Heartburn
  • Nonswallowing chest pain
  • Regurgitation

Children (1-11 years)

  • Stomach pain
  • Heartburn
  • Acid reflux
  • Regurgitation
  • Vomiting
  • Difficulty swallowing
  • Food getting stuck
  • Food refusal
INDICATION

DUPIXENT is indicated for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with
eosinophilic esophagitis (EoE).

Help appropriate patients benefit from the first FDA-approved treatment for EoE

PARTNER WITH A SPECIALIST

Patient profiles are representative and are not actual DUPIXENT patients.
PPI, proton pump inhibitor.

DUPIXENT MyWay ®

Get patient access support and information about benefits investigations, prior authorizations, and medical necessity and appeal letters.

Discover up to 52 weeks
of data across clinical,
histologic,
and
endoscopic endpoints2-4

VIEW THE DATA